|
|
Post by mnholdem on Oct 20, 2016 7:42:19 GMT -5
Why You Still Have to Bolus with the First Artificial Pancreas
JDRF chief mission officer Dr. Aaron Kowalski says we don’t yet have the tools for a fully automated artificial pancreas.
Insulin Nation - Oct 4, 2016
Source: insulinnation.com/treatment/why-you-still-have-to-bolus-with-the-first-artificial-pancreas/
Excerpt:
There has been vocal criticism among some in the Type 1 diabetes community that the [Medtronic] 670G is not automated enough to be considered an artificial pancreas. For example, users of the pump system will still have to bolus for meals. Dr. Kowalski said that there is still more work to be done on developing the technology and insulin formulations to make a fully automated artificial pancreas possible. The 670G should be seen as a step toward full automation.
“The hybrid closed loop (system) is on the road to a fully automated artificial pancreas,” he said.
A chief hurdle toward full automation is that the insulin currently on the market is not fast-absorbing enough for the bolus corrections needed in an automated system. Neither Dr. Kowalski nor anyone at JDRF answered a question posed by Insulin Nation, during the forum and on Twitter, of why insulin companies failed to develop the insulin formulation necessary for such a system during a time of record profits from high insulin prices.
---
Insulin "currently on the market is not fast-absorbing enough" for the bolus corrections needed? Sounds like a job for Afrezza! 
|
|
|
|
Post by liane on Oct 20, 2016 7:51:58 GMT -5
Insulin "currently on the market is not fast-absorbing enough" for the bolus corrections needed? Sounds like a job for Afrezza!
Duh!!!    |
|
|
|
Post by mnholdem on Oct 20, 2016 8:01:17 GMT -5
IMO, marketing should be issuing press releases that heighten awareness of how Afrezza's speed is the perfect fit for Medtronic's new AP.
|
|
|
|
Post by goyocafe on Oct 20, 2016 12:24:55 GMT -5
IMO, marketing should be issuing press releases that heighten awareness of how Afrezza's speed is the perfect fit for Medtronic's new AP. I can only hope that one activity occurring behind the scenes is a label change so this attribute of Afrezza can be fully capitalized. I hate using that word "hope" again, but we just don't know everything they're working on. |
|
|
|
Post by peppy on Oct 20, 2016 12:37:12 GMT -5
Why You Still Have to Bolus with the First Artificial Pancreas
JDRF chief mission officer Dr. Aaron Kowalski says we don’t yet have the tools for a fully automated artificial pancreas.
Insulin Nation - Oct 4, 2016
Source: insulinnation.com/treatment/why-you-still-have-to-bolus-with-the-first-artificial-pancreas/
Excerpt:
There has been vocal criticism among some in the Type 1 diabetes community that the [Medtronic] 670G is not automated enough to be considered an artificial pancreas. For example, users of the pump system will still have to bolus for meals. Dr. Kowalski said that there is still more work to be done on developing the technology and insulin formulations to make a fully automated artificial pancreas possible. The 670G should be seen as a step toward full automation.
“The hybrid closed loop (system) is on the road to a fully automated artificial pancreas,” he said.
A chief hurdle toward full automation is that the insulin currently on the market is not fast-absorbing enough for the bolus corrections needed in an automated system. Neither Dr. Kowalski nor anyone at JDRF answered a question posed by Insulin Nation, during the forum and on Twitter, of why insulin companies failed to develop the insulin formulation necessary for such a system during a time of record profits from high insulin prices.
---
Insulin "currently on the market is not fast-absorbing enough" for the bolus corrections needed? Sounds like a job for Afrezza!
Artificial pancreas is a metaphor. |
|
|
|
Post by mnholdem on Oct 20, 2016 13:20:43 GMT -5
IMO, marketing should be issuing press releases that heighten awareness of how Afrezza's speed is the perfect fit for Medtronic's new AP. I can only hope that one activity occurring behind the scenes is a label change so this attribute of Afrezza can be fully capitalized. I hate using that word "hope" again, but we just don't know everything they're working on. You may want to check out my new thread in the All About MannKind section:
mnkd.proboards.com/thread/6513/fda-label-changes-plural-afrezza
|
|
